- Tytuł:
- Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study
- Autorzy:
- Źródło:
- In The Lancet Oncology November 2019 20(11):1576-1586
Czasopismo naukowe